$SCLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SCICLONE PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SCICLONE PHARMACEUTICALS INC. Get notifications about new insider transactions in SCICLONE PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 40,000 | 72,400 | 46,901 | |
| Dec 22 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 23,099 | 41,809 | 86,901 | |
| Dec 22 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.40 | 6,901 | 71,748 | 86,784 | 93.7 K to 86.8 K (-7.37 %) |
| Dec 22 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 6,901 | 12,491 | 93,685 | 86.8 K to 93.7 K (+7.95 %) |
| Dec 22 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.54 | 40,000 | 421,548 | 86,784 | 126.8 K to 86.8 K (-31.55 %) |
| Dec 22 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 40,000 | 72,400 | 126,784 | 86.8 K to 126.8 K (+46.09 %) |
| Dec 22 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.61 | 23,099 | 245,071 | 86,784 | 109.9 K to 86.8 K (-21.02 %) |
| Dec 22 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 23,099 | 41,809 | 109,883 | 86.8 K to 109.9 K (+26.62 %) |
| Nov 23 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 14,147 | 25,606 | 110,000 | |
| Nov 23 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 40,000 | 72,400 | 124,147 | |
| Nov 23 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 15,853 | 28,694 | 164,147 | |
| Nov 23 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.20 | 14,147 | 144,265 | 86,784 | 100.9 K to 86.8 K (-14.02 %) |
| Nov 23 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 14,147 | 25,606 | 100,931 | 86.8 K to 100.9 K (+16.30 %) |
| Nov 23 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.22 | 40,000 | 408,764 | 86,784 | 126.8 K to 86.8 K (-31.55 %) |
| Nov 23 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 40,000 | 72,400 | 126,784 | 86.8 K to 126.8 K (+46.09 %) |
| Nov 23 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.23 | 15,853 | 162,149 | 86,784 | 102.6 K to 86.8 K (-15.45 %) |
| Nov 23 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 15,853 | 28,694 | 102,637 | 86.8 K to 102.6 K (+18.27 %) |
| Nov 15 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 24,699 | 44,705 | 180,000 | |
| Nov 15 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 5,301 | 9,595 | 204,699 | |
| Nov 15 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.33 | 24,699 | 255,086 | 86,784 | 111.5 K to 86.8 K (-22.15 %) |
| Nov 15 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 24,699 | 44,705 | 111,483 | 86.8 K to 111.5 K (+28.46 %) |
| Nov 15 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.01 | 5,301 | 53,051 | 86,784 | 92.1 K to 86.8 K (-5.76 %) |
| Nov 15 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 5,301 | 9,595 | 92,085 | 86.8 K to 92.1 K (+6.11 %) |
| Nov 15 2016 | SCLN | SCICLONE PHARMACEU ... | Chern Carey | General Counsel | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Nov 15 2016 | SCLN | SCICLONE PHARMACEU ... | Chern Carey | General Counsel | Option Exercise | A | 10.35 | 41,356 | 428,035 | 41,356 | |
| Nov 15 2016 | SCLN | SCICLONE PHARMACEU ... | Chern Carey | General Counsel | Option Exercise | A | 10.35 | 38,644 | 399,965 | 38,644 | |
| Oct 28 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.81 | 40,000 | 72,400 | 210,000 | |
| Oct 28 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 9.30 | 40,000 | 371,892 | 86,784 | 126.8 K to 86.8 K (-31.55 %) |
| Oct 28 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.81 | 40,000 | 72,400 | 126,784 | 86.8 K to 126.8 K (+46.09 %) |
| Oct 27 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 5.97 | 48,995 | 292,500 | 0 | |
| Oct 27 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 5.97 | 40,625 | 242,531 | 9,375 | |
| Oct 27 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 4.52 | 45,208 | 204,340 | 24,792 | |
| Oct 27 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.00 | 40,625 | 406,250 | 0 | 40.6 K to 0 (-100.00 %) |
| Oct 27 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 5.97 | 40,625 | 242,531 | 40,625 | 0 to 40.6 K |
| Oct 27 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.00 | 48,995 | 489,950 | 0 | 49 K to 0 (-100.00 %) |
| Oct 27 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 5.97 | 48,995 | 292,500 | 48,995 | 0 to 49 K |
| Oct 27 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.00 | 45,208 | 452,080 | 0 | 45.2 K to 0 (-100.00 %) |
| Oct 27 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 4.52 | 45,208 | 204,340 | 45,208 | 0 to 45.2 K |
| Oct 27 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.00 | 15,064 | 150,640 | 0 | 15.1 K to 0 (-100.00 %) |
| Oct 27 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.00 | 70 | 700 | 15,064 | 15.1 K to 15.1 K (-0.46 %) |
| Oct 19 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 5.97 | 1,005 | 6,000 | 98,995 | |
| Oct 19 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.00 | 470 | 4,700 | 15,134 | 15.6 K to 15.1 K (-3.01 %) |
| Oct 19 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.00 | 1,005 | 10,050 | 15,604 | 16.6 K to 15.6 K (-6.05 %) |
| Oct 19 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 5.97 | 1,005 | 6,000 | 16,609 | 15.6 K to 16.6 K (+6.44 %) |
| Sep 29 2016 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Option Exercise | M | 5.22 | 33,333 | 173,998 | 0 | |
| Sep 29 2016 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Option Exercise | M | 5.10 | 7,648 | 39,005 | 0 | |
| Sep 29 2016 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Buy | M | 5.22 | 33,333 | 173,998 | 70,000 | 36.7 K to 70 K (+90.91 %) |
| Sep 29 2016 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Buy | M | 5.10 | 7,648 | 39,005 | 36,667 | 29 K to 36.7 K (+26.36 %) |
| Aug 30 2016 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Sell | S | 10.33 | 7,540 | 77,887 | 0 | 7.5 K to 0 (-100.00 %) |
| Aug 30 2016 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Sell | S | 10.31 | 10,000 | 103,119 | 7,540 | 17.5 K to 7.5 K (-57.01 %) |
| Aug 30 2016 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Sell | S | 10.25 | 7,500 | 76,891 | 17,540 | 25 K to 17.5 K (-29.95 %) |
| Aug 29 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.35 | 1,872 | 19,370 | 15,604 | 17.5 K to 15.6 K (-10.71 %) |
| Aug 18 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 1.08 | 100,000 | 108,000 | 100,000 | |
| Aug 18 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Sell | S | 10.00 | 501,875 | 5,018,750 | 86,380 | 588.3 K to 86.4 K (-85.32 %) |
| Aug 18 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 1.08 | 100,000 | 108,000 | 588,255 | 488.3 K to 588.3 K (+20.48 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 0.00 | 50,000 | 0 | 325,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 0.00 | 5,000 | 0 | 375,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | M | 0.00 | 3,500 | 0 | 380,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Option Exercise | A | 0.00 | 40,000 | 0 | 383,500 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Payment of Exercise | F | 10.41 | 2,610 | 27,170 | 488,255 | 490.9 K to 488.3 K (-0.53 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Payment of Exercise | F | 10.41 | 26,090 | 271,597 | 490,865 | 517 K to 490.9 K (-5.05 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Payment of Exercise | F | 10.41 | 1,827 | 19,019 | 516,955 | 518.8 K to 517 K (-0.35 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 0.00 | 50,000 | 0 | 518,782 | 468.8 K to 518.8 K (+10.67 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 0.00 | 5,000 | 0 | 468,782 | 463.8 K to 468.8 K (+1.08 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Blobel Friedhelm | President & CEO | Buy | M | 0.00 | 3,500 | 0 | 463,782 | 460.3 K to 463.8 K (+0.76 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 3,000 | 0 | 188,500 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 25,000 | 0 | 191,500 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | M | 0.00 | 12,500 | 0 | 216,500 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Option Exercise | A | 0.00 | 30,000 | 0 | 229,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Sell | S | 10.41 | 3,000 | 31,230 | 0 | 3 K to 0 (-100.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Buy | M | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Sell | S | 10.41 | 25,000 | 260,250 | 0 | 25 K to 0 (-100.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Sell | S | 10.41 | 12,500 | 130,125 | 0 | 12.5 K to 0 (-100.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Zhao Hong | CEO, China Operatio ... | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | M | 0.00 | 1,000 | 0 | 17,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | A | 0.00 | 10,000 | 0 | 18,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | M | 8.83 | 9,333 | 82,410 | 18,667 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | M | 5.19 | 12,187 | 63,251 | 0 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | M | 4.53 | 2,812 | 12,738 | 2,500 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Option Exercise | M | 4.52 | 7,500 | 33,900 | 16,667 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Sell | S | 10.41 | 1,000 | 10,410 | 0 | 1,000 to 0 (-100.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Buy | M | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Sell | S | 10.36 | 12,187 | 126,270 | 0 | 12.2 K to 0 (-100.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Buy | M | 5.19 | 12,187 | 63,251 | 12,187 | 0 to 12.2 K |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Sell | S | 10.36 | 2,812 | 29,135 | 0 | 2.8 K to 0 (-100.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Buy | M | 4.53 | 2,812 | 12,738 | 2,812 | 0 to 2.8 K |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Sell | S | 10.36 | 7,500 | 77,708 | 0 | 7.5 K to 0 (-100.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Buy | M | 4.52 | 7,500 | 33,900 | 7,500 | 0 to 7.5 K |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Sell | S | 10.36 | 9,333 | 96,699 | 0 | 9.3 K to 0 (-100.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Xie Lan | VP Finance, China C ... | Buy | M | 8.83 | 9,333 | 82,410 | 9,333 | 0 to 9.3 K |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | M | 0.00 | 1,250 | 0 | 18,750 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Option Exercise | A | 0.00 | 10,000 | 0 | 20,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Low Raymond Anthony | VP, Finance & Contr ... | Buy | M | 0.00 | 1,250 | 0 | 10,908 | 9.7 K to 10.9 K (+12.94 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Meng Chuncai | Gen. Counsel & VP C ... | Option Exercise | M | 0.00 | 750 | 0 | 5,250 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Meng Chuncai | Gen. Counsel & VP C ... | Option Exercise | M | 8.83 | 7,000 | 61,810 | 14,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Meng Chuncai | Gen. Counsel & VP C ... | Option Exercise | M | 4.52 | 23,333 | 105,465 | 30,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Meng Chuncai | Gen. Counsel & VP C ... | Sell | S | 10.41 | 750 | 7,808 | 0 | 750 to 0 (-100.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Meng Chuncai | Gen. Counsel & VP C ... | Buy | M | 0.00 | 750 | 0 | 750 | 0 to 750 |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Meng Chuncai | Gen. Counsel & VP C ... | Sell | S | 10.41 | 7,000 | 72,870 | 0 | 7 K to 0 (-100.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Meng Chuncai | Gen. Counsel & VP C ... | Buy | M | 8.83 | 7,000 | 61,810 | 7,000 | 0 to 7 K |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Meng Chuncai | Gen. Counsel & VP C ... | Sell | S | 10.41 | 23,333 | 242,897 | 0 | 23.3 K to 0 (-100.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Meng Chuncai | Gen. Counsel & VP C ... | Buy | M | 4.52 | 23,333 | 105,465 | 23,333 | 0 to 23.3 K |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | King Robert | SVP of Prod. Dev/Su ... | Option Exercise | M | 0.00 | 2,000 | 0 | 13,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | King Robert | SVP of Prod. Dev/Su ... | Option Exercise | M | 4.52 | 46,667 | 210,935 | 33,333 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | King Robert | SVP of Prod. Dev/Su ... | Sell | S | 10.41 | 2,000 | 20,820 | 16,844 | 18.8 K to 16.8 K (-10.61 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | King Robert | SVP of Prod. Dev/Su ... | Buy | M | 0.00 | 2,000 | 0 | 18,844 | 16.8 K to 18.8 K (+11.87 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | King Robert | SVP of Prod. Dev/Su ... | Sell | S | 10.41 | 46,667 | 485,803 | 16,844 | 63.5 K to 16.8 K (-73.48 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | King Robert | SVP of Prod. Dev/Su ... | Buy | M | 4.52 | 46,667 | 210,935 | 63,511 | 16.8 K to 63.5 K (+277.05 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | M | 3.01 | 30,000 | 90,300 | 0 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | M | 2.61 | 30,000 | 78,300 | 0 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | M | 2.23 | 30,000 | 66,900 | 0 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | M | 1.75 | 30,000 | 52,500 | 0 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Sell | S | 10.37 | 30,000 | 311,181 | 24,363 | 54.4 K to 24.4 K (-55.18 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Buy | M | 2.61 | 30,000 | 78,300 | 54,363 | 24.4 K to 54.4 K (+123.14 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Sell | S | 10.37 | 30,000 | 311,181 | 24,363 | 54.4 K to 24.4 K (-55.18 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Buy | M | 1.75 | 30,000 | 52,500 | 54,363 | 24.4 K to 54.4 K (+123.14 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Sell | S | 10.37 | 30,000 | 311,181 | 24,363 | 54.4 K to 24.4 K (-55.18 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Buy | M | 2.23 | 30,000 | 66,900 | 54,363 | 24.4 K to 54.4 K (+123.14 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Sell | S | 10.37 | 30,000 | 311,181 | 24,363 | 54.4 K to 24.4 K (-55.18 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Buy | M | 3.01 | 30,000 | 90,300 | 54,363 | 24.4 K to 54.4 K (+123.14 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 3,000 | 0 | 188,500 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 3,000 | 0 | 188,500 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 12,500 | 0 | 191,500 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 12,500 | 0 | 191,500 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 25,000 | 0 | 204,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | M | 0.00 | 25,000 | 0 | 204,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | A | 0.00 | 30,000 | 0 | 229,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Option Exercise | A | 0.00 | 30,000 | 0 | 229,000 | |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.62 | 7,802 | 82,837 | 17,476 | 25.3 K to 17.5 K (-30.86 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Sell | S | 10.62 | 7,802 | 82,837 | 17,476 | 25.3 K to 17.5 K (-30.86 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Payment of Exercise | F | 10.41 | 4,698 | 48,906 | 25,278 | 30 K to 25.3 K (-15.67 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Payment of Exercise | F | 10.41 | 4,698 | 48,906 | 25,278 | 30 K to 25.3 K (-15.67 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Payment of Exercise | F | 10.41 | 1,128 | 11,742 | 29,976 | 31.1 K to 30 K (-3.63 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Payment of Exercise | F | 10.41 | 1,128 | 11,742 | 29,976 | 31.1 K to 30 K (-3.63 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Payment of Exercise | F | 10.41 | 9,396 | 97,812 | 31,104 | 40.5 K to 31.1 K (-23.20 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Payment of Exercise | F | 10.41 | 9,396 | 97,812 | 31,104 | 40.5 K to 31.1 K (-23.20 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 3,000 | 0 | 40,500 | 37.5 K to 40.5 K (+8.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 3,000 | 0 | 40,500 | 37.5 K to 40.5 K (+8.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 12,500 | 0 | 37,500 | 25 K to 37.5 K (+50.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 12,500 | 0 | 37,500 | 25 K to 37.5 K (+50.00 %) |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Aug 16 2016 | SCLN | SCICLONE PHARMACEU ... | Cheung Wilson Wai-Shun | CFO & Senior VP, Fi ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Jun 13 2016 | SCLN | SCICLONE PHARMACEU ... | CHANG NANCY T | Director | Option Exercise | A | 14.00 | 30,000 | 419,850 | 30,000 | |
| Jun 13 2016 | SCLN | SCICLONE PHARMACEU ... | Li Simon | Director | Option Exercise | A | 14.00 | 30,000 | 419,850 | 30,000 | |
| Jun 13 2016 | SCLN | SCICLONE PHARMACEU ... | SAXE JON S | Director | Option Exercise | A | 14.00 | 30,000 | 419,850 | 30,000 | |
| Jun 13 2016 | SCLN | SCICLONE PHARMACEU ... | LAPOINTE ANTHONY GREGG | Director | Option Exercise | A | 14.00 | 30,000 | 419,850 | 30,000 | |
| Jun 13 2016 | SCLN | SCICLONE PHARMACEU ... | Hawkins Richard J | Director | Option Exercise | A | 14.00 | 30,000 | 419,850 | 30,000 | |
| May 17 2016 | SCLN | SCICLONE PHARMACEU ... | Meng Chuncai | Gen. Counsel & VP C ... | Option Exercise | A | 0.00 | 3,000 | 0 | 6,000 | |
| May 17 2016 | SCLN | SCICLONE PHARMACEU ... | Meng Chuncai | Gen. Counsel & VP C ... | Option Exercise | A | 12.71 | 21,000 | 266,910 | 21,000 |